Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Safe |
4/02 | 0,016 EUR
-12,83% |
-12,83% |
Sage Therapeutics Inc |
4/02 | 7,240 USD
-0,28% |
-0,28% |
|
Salarius Pharmaceuticals Inc |
4/02 | 2,130 USD
-2,29% |
-2,29% |
|
Sanara MedTech Inc |
4/02 | 35,480 USD
-0,25% |
-0,25% |
|
Sangamo Therapeutics Inc |
4/02 | 1,240 USD
+5,98% |
+5,98% |
|
Sanofi |
4/02 | 102,680 EUR
-1,70% |
-1,70% |
|
Sanofi |
4/02 | 53,500 USD
+0,28% |
+0,28% |
|
Sarepta Therapeutics Inc |
4/02 | 114,080 USD
+0,24% |
+0,24% |
Sartorius AG |
4/02 | 213,000 EUR
-2,52% |
-2,52% |
|
Sartorius AG |
4/02 | 264,700 EUR
-2,72% |
-2,72% |
|
Sartorius Stedim Biotech S.A. |
4/02 | 214,700 EUR
-2,23% |
-2,23% |
|
Savara Inc |
4/02 | 2,860 USD
+2,14% |
+2,14% |
Scancell Hldgs Plc |
4/02 | 9,250 GBX
-0,54% |
-0,54% |
|
Scholar Rock Holding Corp |
4/02 | 40,025 USD
-0,06% |
-0,06% |
|
scPharmaceuticals Inc |
4/02 | 3,350 USD
+4,69% |
+4,69% |
|
Scynexis Inc |
4/02 | 1,090 USD
-0,46% |
-0,46% |
|
SDI Group Plc. |
3/02 | 52,500 GBX
-1,87% |
-1,87% |
|
SELLAS Life Sciences Group Inc |
4/02 | 1,490 USD
+0,68% |
+0,68% |
|
Semler Scientific |
4/02 | 51,240 USD
+1,55% |
+1,55% |
|
SenesTech Inc |
4/02 | 3,030 USD
+8,60% |
+8,60% |
|
Sensorion |
4/02 | 0,630 EUR
-0,63% |
-0,63% |
|
Sensus Healthcare Inc |
4/02 | 8,440 USD
+4,07% |
+4,07% |
Sequana Medical |
4/02 | 2,200 EUR
-5,17% |
-5,17% |
|
Seres Therapeutics Inc |
4/02 | 0,806 USD
-3,02% |
-3,02% |
Sernova Corp. |
4/02 | 0,215 CAD
+4,88% |
+4,88% |
|
Shattuck Labs Inc |
4/02 | 1,230 USD
-4,28% |
-4,28% |
|
Shield Therapeutics plc |
4/02 | 2,850 GBX
+5,56% |
+5,56% |
|
SI-BONE Inc |
4/02 | 17,920 USD
+5,29% |
+5,29% |
|
SIGA Technologies Inc |
4/02 | 5,830 USD
+0,87% |
+0,87% |
|
Silence Therapeutics Plc |
4/02 | 5,610 USD
+10,87% |
+10,87% |
|
SINTX Technologies Inc |
4/02 | 3,100 USD
+0,65% |
+0,65% |
|
Sirona Biochem Corp |
4/02 | 0,060 CAD
0,00% |
0,00% |
|
SkinBioTherapeutics Plc |
4/02 | 18,750 GBX
+6,38% |
+6,38% |
|
Smith & Nephew plc |
4/02 | 25,740 USD
+1,46% |
+1,46% |
|
Smith & Nephew plc |
4/02 | 1.033,500 GBX
+0,49% |
+0,49% |
|
Sol-Gel Technologies Ltd |
4/02 | 0,710 USD
-2,99% |
-2,99% |
|
Soleno Therapeutics Inc |
4/02 | 49,780 USD
+2,60% |
+2,60% |
|
Solid Biosciences Inc |
4/02 | 3,040 USD
-3,49% |
-3,49% |
|
Soligenix Inc |
4/02 | 2,280 USD
0,00% |
0,00% |
|
Sonnet BioTherapeutics Holdings Inc |
4/02 | 1,615 USD
+1,57% |
+1,57% |
|
Sonoma Pharmaceuticals Inc. |
4/02 | 2,690 USD
+4,26% |
+4,26% |
|
Sorrento Therapeutics Inc |
4/02 | 0,000 USD
-25,00% |
-25,00% |
|
Spectral Medical Inc |
4/02 | 0,550 CAD
+1,85% |
+1,85% |
|
Spero Therapeutics Inc |
4/02 | 0,753 USD
-6,19% |
-6,19% |
|
Spineguard |
4/02 | 0,204 EUR
-2,16% |
-2,16% |
|
Spineway |
4/02 | 0,092 EUR
+1,77% |
+1,77% |
|
SpringWorks Therapeutics Inc |
4/02 | 38,400 USD
+7,20% |
+7,20% |
|
Spruce Biosciences Inc |
4/02 | 0,397 USD
+4,50% |
+4,50% |
|
Staar Surgical Co. |
4/02 | 23,220 USD
-0,68% |
-0,68% |
|
Stereotaxis Inc |
4/02 | 2,480 USD
+4,64% |
+4,64% |
|
Steris Plc |
4/02 | 219,400 USD
+0,49% |
+0,49% |
|
Stoke Therapeutics Inc |
4/02 | 12,600 USD
+9,38% |
+9,38% |
|
STRATA Skin Sciences Inc |
4/02 | 2,765 USD
-2,30% |
-2,30% |
|
Stratec SE |
4/02 | 35,700 EUR
+1,28% |
+1,28% |
|
Stryker |
4/02 | 392,390 USD
+0,32% |
+0,32% |
|
Summit Therapeutics Inc |
4/02 | 20,620 USD
+3,20% |
+3,20% |
|
Sunshine Biopharma Inc |
4/02 | 2,700 USD
+1,89% |
+1,89% |
|
Supernus Pharmaceuticals Inc |
4/02 | 40,000 USD
+7,07% |
+7,07% |
|
Surgical Innovations Group |
28/01 | 0,525 GBX
-4,55% |
-4,55% |
|
Surmodics, Inc. |
4/02 | 33,620 USD
-1,32% |
-1,32% |
|
Sutro Biopharma Inc |
4/02 | 1,990 USD
+4,74% |
+4,74% |
|
Synairgen plc |
4/02 | 1,948 GBX
-5,23% |
-5,23% |
|
Syndax Pharmaceuticals Inc |
4/02 | 14,410 USD
+0,49% |
+0,49% |
|
Synlogic Inc |
4/02 | 1,320 USD
0,00% |
0,00% |
|
Syros Pharmaceuticals Inc. |
4/02 | 0,169 USD
+1,99% |
+1,99% |